Mirae Asset Global ETFs Holdings
DNA icon

Mirae Asset Global ETFs Holdings’s Ginkgo Bioworks DNA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Buy
19,651
+476
+2% +$3.96K ﹤0.01% 2592
2025
Q4 		$159K Buy
19,175
+1,113
+6% +$12K ﹤0.01% 2456
2025
Q3 		$263K Sell
18,062
-3,227
-15% -$38.6K ﹤0.01% 2181
2025
Q2 		$240K Buy
+21,289
New +$165K ﹤0.01% 2189

Other funds holding DNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return